Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 47952-47953 [E8-18904]
Download as PDF
47952
Federal Register / Vol. 73, No. 159 / Friday, August 15, 2008 / Notices
Dated: August 11, 2008.
Christine M. Branche,
Acting Director, National Institute for
Occupational Safety and Health.
[FR Doc. E8–18909 Filed 8–14–08; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Request for Planning Ideas for
Development of an AHRQ Innovations
Research Portfolio
Agency for Healthcare Research
and Quality (AHRQ), HHS.
AGENCY:
ACTION:
Notice of Request for Ideas.
SUMMARY: AHRQ is establishing a new
research portfolio, the Innovations
Portfolio. The Portfolio goal is to
identify and support research that has
the potential to accelerate
improvements in the organization,
delivery, and management of healthcare.
AHRQ seeks ideas on priority topics and
activities that should be addressed as
components of the Innovations
Portfolio.
Please submit comments no later
than October 14, 2008.
DATES:
Submissions should be brief
(no more than three pages per
recommendation), and should be in the
form of a letter or e-mail, preferably
with an electronic file in a standard
word processing format as an e-mail
attachment. Responses to this request
should be submitted to Francis D.
Chesley, Jr., M.D., Agency for Health
Care Research and Quality, 540 Gaither
Road, Room 2034, Rockville, MD 20850,
FAX: (301) 427–1562, e-mail:
francis.chesley@ahrq.hhs.gov.
In order to facilitate handling of
submissions, please include full
information about the person submitting
the recommendation: (a) Name, (b) title;
(c) organization, (d) mailing address, (e)
telephone number, and (f) e-mail
address. Please do not use acronyms.
ADDRESSES:
mstockstill on PROD1PC66 with NOTICES
FOR FURTHER INFORMATION CONTACT:
Francis D. Chesley, Jr., M.D., (301) 427–
1449 or at francis.chesley@ahrg.hhs.gov.
All responses will be available for
public inspection at AHRQ’s Office of
Extramural Research, Education, and
Priority Populations weekdays between
8:30 a.m. and 5 p.m. Arrangements for
reviewing the submissions may be made
by calling (301) 427–1449.
SUPPLEMENTARY INFORMATION:
VerDate Aug<31>2005
19:03 Aug 14, 2008
Jkt 214001
Background
The Innovations Portfolio is focused
on creating resources and opportunity
for exploration and discovery. The
Innovations Portfolio was created to
identify and support research that has
the potential for high impact. These
ideas will be novel and span a diverse
array of disciplines. The portfolio will
foster and nurture ideas and projects
that have the potential to lead to highly
innovative solutions that may lead to
significant advances in healthcare
organization, delivery, and
management. Research and activities
supported under the Innovations
Portfolio will reflect ideas substantially
different from those already being
pursued by AHRQ. The portfolio will
fund a transformative research agenda to
solve pressing healthcare problems.
Thus, the main focus of the portfolio is
problem solving in order to accelerate
improvement in healthcare.
Ideas are sought for topics to be
supported by the Innovations Portfolio.
Ideas are also sought regarding specific
strategies to foster innovative
approaches and programs. Comments
and ideas may address new and
emerging priority issues and areas that
should be the focus of research in the
Innovations Portfolio, mechanisms for
identifying and engaging partners for
this important work, or any related
topic.
Dated: August 4, 2008.
Carolyn M. Clancy,
Director.
[FR Doc. E8–18671 Filed 8–14–08; 8:45 am]
BILLING CODE 4160–90–M
contact person listed below. If you will
require a sign language interpretator, or have
other special needs, please notify the contact
person by 4:30 E.S.T. on September 9, 2008.
Purpose: The Interagency Committee on
Smoking and Health advises the Secretary,
Department of Health and Human Services,
and the Assistant Secretary for Health in the
(a) coordination of all research and education
programs and other activities within the
Department and with other federal, state,
local and private agencies and (b)
establishment and maintenance of liaison
with appropriate private entities, federal
agencies, and state and local public health
agencies with respect to smoking and health
activities.
Matters to be Discussed: The agenda will
focus on ‘‘NicotineAddiction.’’
Contact Person for More Information:
Substantive program information as well as
summaries of the meeting and roster of
committee members may be obtained from
the internet at http: //www.cdc.gov/tobacco
in mid-December or from Ms. Monica L.
Swann, Management and Program Analyst,
Office on Smoking and Health, Centers for
Disease Control and Prevention, 4770 Buford
Highway, M/S K50, Atlanta, Georgia 30341,
Telephone: 770–488–5278.
Agenda items are subject to change as
priorities dictate.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: August 11, 2008.
Lorenzo J. Falgiano,
Acting Director, Management Analysis and
Service Office, Centers for Disease Control
and Prevention.
[FR Doc. E8–18899 Filed 8–14–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
The National Center for Chronic
Disease Prevention and Health
Promotion
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention announces the
following meeting.
Name: Interagency Committee on Smoking
and Health.
Time and Date: 9 a.m.—4:30 p.m.,
September 16, 2008.
Place: Hilton Washington Embassy Row,
Ambassador Room, 2015 Massachusetts
Avenue, NW., Washington, DC 20036.
Telephone: 202–939–4124.
Status: Open to the public, limited only by
the space available. Those who wish to
attend are encouraged to register with the
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention, announces the
following meeting for the
aforementioned subcommittee:
Time and Date: 9:30 a.m.—5 p.m., August
20, 2008.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018.
Telephone (859)334–4611, Fax (859)334–
4619.
E:\FR\FM\15AUN1.SGM
15AUN1
Federal Register / Vol. 73, No. 159 / Friday, August 15, 2008 / Notices
mstockstill on PROD1PC66 with NOTICES
Status: Open to the public, but without a
public comment period. To access by
conference call dial the following
information 1(866)659–0537, Participant Pass
Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development
ofprobability of causation guidelines that
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2009.
Purpose: The Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee for Dose
Reconstruction Reviews was established to
aid the Advisory Board in carrying out its
duty to advise the Secretary, HHS, on dose
reconstruction.
Matters to be Discussed: The agenda for the
Subcommittee meeting includes a discussion
of cases under review from the 6th, 7th, and
8th sets of individual dose reconstructions;
and selection of cases for future review.
The agenda is subject to change as
priorities dictate.
ABRWH determines that agency business
requires its consideration of this matter on
less than 15 days notice to the public and
that no earlier notice of this meeting was
possible.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact personbelow well in advance of
the meeting.
Contact Person for More Information:
Christine Branche, Ph.D., Executive
Secretary, NIOSH, CDC, 395 E. Street, SW.,
VerDate Aug<31>2005
19:03 Aug 14, 2008
Jkt 214001
Suite 9200, Washington, DC 20201,
Telephone (513)533–6800, Toll Free
1(800)CDC–INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: August 11, 2008.
Lorenzo J. Falgiano,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E8–18904 Filed 8–14–08; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10260 and CMS–
10256]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: New collection; Title of
Information Collection: Medicare
Advantage (MA) Disclosure
Requirements; Use: The information
collection requirements are mandated
by 42 CFR 422.111 and 422.80. MA
organizations will be required to notify
plan members of the coming year’s
changes using a combined standardized
document. MA organizations and
potential MA organizations (applicants)
will use the information to comply with
AGENCY:
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
47953
the eligibility requirements and the MA
contract requirements. CMS will use
this information to ensure that correct
information is disclosed to Medicare
beneficiaries, both potential enrollees
and enrollees. Form Number: CMS–
10260 (OMB# 0938–New); Frequency:
Yearly; Affected Public: Business or
other for-profit; Number of
Respondents: 670; Total Annual
Responses: 670; Total Annual Hours:
8040.
2. Type of Information Collection
Request: New collection; Title of
Information Collection: Medicare Care
Management performance (MCMP)
Demonstration; Use: Section 649 of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) requires the Secretary of
the U.S. Department of Health and
Human Services to establish a pay-forperformance (P4P) demonstration
program with physicians to meet the
needs of eligible beneficiaries through
the adoption and use of health
information technology (HIT) and
evidence-based outcome measures. The
Medicare Care Management
Performance Demonstration was
established in response to the MMA.
Mathematica Policy Research, Inc. is
conducting an evaluation of the MCMP
on behalf of CMS. The goals of the
three-year demonstration are to improve
quality of care to eligible fee-for-service
Medicare beneficiaries and encourage
the implementation and use of HIT. The
specific objectives are to promote
continuity of care, help stabilize
medical conditions, prevent or
minimize acute exacerbations of chronic
conditions, and reduce adverse health
outcomes. The MMA authorizes a total
of four sites in both urban and rural
areas. The demonstration sites are in
Arkansas, California, Massachusetts,
and Utah. The MCMP demonstration
will target practices serving at least 50
traditional fee-for-service Medicare
beneficiaries with congestive heart
failure, coronary heart disease, and
diabetes for whom they provide primary
care.
An impact analysis using a
comparison group design will be
conducted as part of the evaluation.
Physician practices in selected nondemonstration States that match most
closely those in demonstration States on
key factors will make up the comparison
group. The impact analysis will use data
from four data sources: (1) A beneficiary
survey, (2) a physician survey, (3)
Medicare claims and eligibility data,
and (4) practice-specific data. This
request relates to the two surveys. Form
Number: CMS–10256 (OMB# 0938–
New); Frequency: Once; Affected Public:
E:\FR\FM\15AUN1.SGM
15AUN1
Agencies
[Federal Register Volume 73, Number 159 (Friday, August 15, 2008)]
[Notices]
[Pages 47952-47953]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18904]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH), National Institute for
Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention, announces the following meeting for the aforementioned
subcommittee:
Time and Date: 9:30 a.m.--5 p.m., August 20, 2008.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron,
Kentucky 41018. Telephone (859)334-4611, Fax (859)334-4619.
[[Page 47953]]
Status: Open to the public, but without a public comment period.
To access by conference call dial the following information
1(866)659-0537, Participant Pass Code 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development ofprobability of causation guidelines that
have been promulgated by the Department of Health and Human Services
(HHS) as a final rule; advice on methods of dose reconstruction
which have also been promulgated by HHS as a final rule; advice on
the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the
compensation program; and advice on petitions to add classes of
workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2009.
Purpose: The Advisory Board is charged with (a) Providing advice
to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class. The Subcommittee for Dose Reconstruction Reviews was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters to be Discussed: The agenda for the Subcommittee meeting
includes a discussion of cases under review from the 6th, 7th, and
8th sets of individual dose reconstructions; and selection of cases
for future review.
The agenda is subject to change as priorities dictate.
ABRWH determines that agency business requires its consideration
of this matter on less than 15 days notice to the public and that no
earlier notice of this meeting was possible.
In the event an individual cannot attend, written comments may
be submitted. Any written comments received will be provided at the
meeting and should be submitted to the contact personbelow well in
advance of the meeting.
Contact Person for More Information: Christine Branche, Ph.D.,
Executive Secretary, NIOSH, CDC, 395 E. Street, SW., Suite 9200,
Washington, DC 20201, Telephone (513)533-6800, Toll Free 1(800)CDC-
INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: August 11, 2008.
Lorenzo J. Falgiano,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E8-18904 Filed 8-14-08; 8:45 am]
BILLING CODE 4163-19-P